{{Infobox person
| name        = Emil Frei III
| image       = Nci-vol-1838-300 Emil Frei.jpg
| alt         = 
| caption     = 
| birth_name  = 
| birth_date  = 1924
| birth_place = 
| death_date  = 2013
| death_place = 
| nationality = 
| other_names = 
| known_for   = cancer research
| occupation  = physician
}}

'''Emil "Tom" Frei III''' (1924-2013) was an American physician and [[oncology|oncologist]]. He was the former director and former physician-in-chief (now emeritus) of the [[Dana-Farber Cancer Institute]] in [[Boston]], [[Massachusetts]]. He was also the Richard and Susan Smith Distinguished Professor of Medicine at [[Harvard Medical School]].<ref>{{cite web|url=http://researchers.dana-farber.org/directory/profile.asp?dbase=main&setsize=16&picture_id=0000013&grouptype_typeid_data=2&gs=r&nxtfmt=r&display=Y&oldurl=Y&try2=Y&pict_id=0000013|title=Official biography|work=Dana-Farber Cancer Institute|accessdate=13 March 2013}}</ref> 

==Education and career==
Frei received his undergraduate degree from [[Colgate University]] in 1944 and his medical degree from [[Yale University]] in 1948. He interned at [[St. Louis University Hospital]] and served as a physician in the [[Korean War]]. He worked at the [[National Cancer Institute]] from 1955 to 1965 and the [[M. D. Anderson Cancer Center]] from 1965 to 1972; while at M.D. Anderson he was the founding director of the Department of Development Therapeutics, which evolved into the Clinical Research Center. He served as physician-in-chief at the Dana-Farber Institute from 1972 to 1991. He is best known for his work on the treatment of lymphomas and childhood and adult leukemia.<ref>{{cite web|url=http://science.education.nih.gov/animalresearch.nsf/ResearcherName/Emil+Frei+III#Q1|title=Emil Frei III|work=Animals in Research|publisher=National Institutes of Health|accessdate=13 March 2013}}</ref>

==Involvement in Cancer Cooperative Group Research==
Frei was one of the founders of the Acute Leukemia Group B which later evolved into the [[Cancer and Leukemia Group B]] (CALGB). He served as the group chair for 16 years, from 1956-1963, and again from 1981-1990. <ref>{{cite web|url=https://www.calgb.org/Public/about/history.php|title=History of CALGB}}</ref> 

==Recognition==
In 1972 he received the [[Lasker-DeBakey Clinical Medical Research Award]] from the [[Lasker Foundation]] "for his outstanding contribution in application of the concept of combination chemotherapy for lymphoma and acute adult leukemia."<ref>{{cite web|url=http://irp.nih.gov/about-us/honors/lasker-award|title=Lasker Award|work=National Institutes of Health|accessdate=13 March 2013}}</ref> Other awards included the Jeffrey A. Gottlieb Memorial Award (1978); NIH Distinguished Alumni Award (1990); Fellow, [[American Academy of Arts and Sciences]] (1999); [[Pollin Prize for Pediatric Research]] (2003); and AARC Lifetime Achievement Award (2004).<ref>{{cite web|url=http://www.lib.utexas.edu/taro/utmda/00038/mda-00038.html|title=Biographical note: Emil Frei, III|work=Making Cancer History Voices Collection|publisher=University of Texas Archival Resources Online|accessdate=13 March 2013}}</ref>

==References==
<references />

== External links ==
*[http://www.lib.utexas.edu/taro/utmda/00038/mda-00038.html Interview with Emil Frei] for the ''Making Cancer History Voices Collection'' at the [[University of Texas]]

{{Persondata <!-- Metadata: see [[Wikipedia:Persondata]]. -->
| NAME              = Frei, Emil
| ALTERNATIVE NAMES =
| SHORT DESCRIPTION =
| DATE OF BIRTH     = 1924
| PLACE OF BIRTH    =
| DATE OF DEATH     = 30 April 2013
| PLACE OF DEATH    =
}}
{{DEFAULTSORT:Frei, Emil}}
[[Category:1924 births]]
[[Category:Harvard Medical School faculty]]
[[Category:Yale School of Medicine alumni]]
[[Category:Colgate University alumni]]
[[Category:Living people]]
[[Category:American physicians]]
[[Category:People from St. Louis, Missouri]]
[[Category:Cancer researchers]]